Inogen Inc — Director's Dealing 2021

Jul 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-07-15

Reporting Person: Huggenberger Raymond (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-15	Common Stock	M	4000	$38.54	Acquired	24583	Direct
2021-07-15	Common Stock	S	6822	$65.8111	Disposed	17761	Direct
2021-07-15	Common Stock	S	178	$66.62	Disposed	17583	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-15	Stock Option (Right to Buy)	$38.54	M	4000	Disposed	2022-05-15	Common Stock (4000)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.

F2: Represents the weighted average share price of an aggregate total of 6,822 shares sold in the price range of $65.258 to $66.23 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the share price of an aggregate total of 178 shares sold at a price of $66.62 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.